Siemens expands AI-driven pharma software portfolio, integrating Dotmatics’ platform to connect drug research, development, ...

Siemens AG announced today that it has completed the acquisition of Dotmatics, a leading provider of Life Sciences R&D ...

Siemens AG has agreed to acquire Dotmatics for $5.1 billion as part of a push to provide more artificial intelligence software to life sciences companies. The German company announced the deal for ...

Siemens estimates that the acquisition of Dotmatics will add about $11 billion to its total addressable market goals. Chief Financial Officer Ralf Thomas said the deal will be financed in part by ...

Siemens has announced an agreement to acquire Boston-based life sciences R&D software provider Dotmatics for $5.1 billion, saying the transaction is a “strategic milestone” that extends Siemens’ ...

Siemens AG said on Wednesday it will acquire U.S.-based Dotmatics for $5.1 billion from private equity firm Insight Partners to strengthen its Life Sciences portfolio. Financing for the deal would ...

Dotmatics is the latest acquisition by Siemens for €4.5 billion. Dotmatics is a research and development technology provider to the life sciences industry.

Siemens to acquire life sciences software leader Dotmatics for $5.1bn. Open in App ...

Siemens is strengthening its research and development activities. A lot of money is being spent on a US company. Siemens is acquiring the US company Dotmatics, a provider of research and development ...

Dotmatics’ revenue growth and high profitability will be immediately accretive to Siemens’ growth, EBITDA margins and free cash flow, prior to any synergies and special items. Siemens expects ...

Investing.com -- Siemens (ETR: SIEGn) has unveiled plans to acquire Dotmatics, a leading provider of research and development (R&D) software for the life sciences industry. The deal, valued at $5. ...